Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1971 Dec;46(250):842–846. doi: 10.1136/adc.46.250.842

Normal Ranges and Diagnostic Value of Serum 5′Nucleotidase and Alkaline Phosphatase Activities in Infancy

Alan Belfield, David M Goldberg
PMCID: PMC1647894  PMID: 5129186

Abstract

Determinations of serum alkaline phosphatase (APase) and 5′nucleotidase (5Nase) activities have been carried out in 159 children investigated for possible disease of liver or bones, and in 147 children in whom these possibilities never arose. The latter group, which served as a control population, showed 5Nase levels very much lower than those encountered in a normal adult population. APase values in this group rose after birth, fell after the first year, and remained stable until puberty when the range increased slightly.

APase was raised in 73% of children with hepatobiliary disease, 65% of children with bone disease, and 28% of children in whom there was no evidence of disease of either type. The corresponding figures for 5Nase activity were 87%, 6%, and 3%, and the degree of increase encountered in hepatobiliary disease was proportionately higher than the increase of APase seen in the same subjects. It is concluded that 5Nase is superior to APase in the diagnosis of hepatobiliary disease in infancy.

Full text

PDF
842

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belfield A., Ellis G., Goldberg D. M. A specific colorimetric 5'-nucleotidase assay utilizing the Berthelot reaction. Clin Chem. 1970 May;16(5):396–401. [PubMed] [Google Scholar]
  2. Belfield A., Goldberg D. M. Activation of serum 5' nucleotidase by magnesium ions and its diagnostic applications. J Clin Pathol. 1969 Mar;22(2):144–151. doi: 10.1136/jcp.22.2.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Belfield A., Goldberg D. M. Application of a continuous spectrophotometric assay for 5'nucleotidase activity in normal subjects and patients with liver and bone disease. Clin Chem. 1969 Oct;15(10):931–939. [PubMed] [Google Scholar]
  4. Belfield A., Goldberg D. M. Comparison of sodium -glycerophosphate and disodium phenyl phosphate as inhibitors of alkaline phosphatase in determination of 5'-nucleotidase activity of human serum. Clin Biochem. 1970 Mar;3(1):105–110. [PubMed] [Google Scholar]
  5. Belfield A., Goldberg D. M. Inhibition of the nucleotidase effect of alkaline phosphatase by beta-glycerophosphate. Nature. 1968 Jul 6;219(5149):73–75. doi: 10.1038/219073a0. [DOI] [PubMed] [Google Scholar]
  6. CLARK L. C., Jr, BECK E. Plasma alkaline phosphatase activity; normative data for growing children. J Pediatr. 1950 Mar;36(3):335–341. doi: 10.1016/s0022-3476(50)80103-8. [DOI] [PubMed] [Google Scholar]
  7. Connell M. D., Dinwoodie A. J. Diagnostic use of serum alkaline phosphatase isoenzymes and 5-nucleotidase. Clin Chim Acta. 1970 Nov;30(2):235–241. doi: 10.1016/0009-8981(70)90108-7. [DOI] [PubMed] [Google Scholar]
  8. DIXON T. F., PURDOM M. Serum 5-nucleotidase. J Clin Pathol. 1954 Nov;7(4):341–343. doi: 10.1136/jcp.7.4.341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. HOFFMANN R. G. STATISTICS IN THE PRACTICE OF MEDICINE. JAMA. 1963 Sep 14;185:864–873. doi: 10.1001/jama.1963.03060110068020. [DOI] [PubMed] [Google Scholar]
  10. Hill P. G., Sammons H. G. An assessment of 5'-nucleotidase as a liver-function test. Q J Med. 1967 Oct;36(144):457–468. [PubMed] [Google Scholar]
  11. KIND P. R., KING E. J. Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine. J Clin Pathol. 1954 Nov;7(4):322–326. doi: 10.1136/jcp.7.4.322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kitchener P. N., Neale F. C., Posen S., Brudenell-Woods J. Alkaline phosphatase in maternal and fetal sera at term and during the puerperium. Am J Clin Pathol. 1965 Dec;44(6):654–661. doi: 10.1093/ajcp/44.6.654. [DOI] [PubMed] [Google Scholar]
  13. SCHWARTZ M. K., BODANSKY O. SERUM 5'-NUCLEOTIDASE IN PATIENTS WITH CANCER. Cancer. 1965 Jul;18:886–892. doi: 10.1002/1097-0142(196507)18:7<886::aid-cncr2820180717>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  14. Smith K., Varon H. H., Race G. J., Paulson D. L., Urschel H. C., Mallams J. T. Serum 5'-nucleotidase in patients with tumor in the liver. Cancer. 1966 Sep;19(9):1281–1285. doi: 10.1002/1097-0142(196609)19:9<1281::aid-cncr2820190914>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  15. WACHSTEIN M., SIGISMONDI R. 5-Nucleotidase activity and adenosine triphosphatase activity in human serums. Am J Clin Pathol. 1958 Dec;30(6):523–527. doi: 10.1093/ajcp/30.6.523. [DOI] [PubMed] [Google Scholar]
  16. van der Slik W., Persijn J. P., Engelsman E., Riethorst A. Serum 5'-nucleotidase. Clin Biochem. 1970 Mar;3(1):59–80. [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES